Panbela Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Panbela Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q1 2024.
  • Panbela Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $103K, a 42.8% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $823K, a 24.4% decline from 2022.
  • Panbela Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.09M, a 15.5% decline from 2021.
  • Panbela Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.29M, a 6.81% increase from 2020.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $103K -$77K -42.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $180K -$154K -46.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $334K +$82K +32.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $252K +$140K +125% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $112K +$102K +1020% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $10K -$1.78M -99.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $1.79M +$872K +94.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $920K +$845K +1127% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2016 $75K +$33K +78.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-21
Q1 2015 $42K -$49K -53.8% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-30
Q1 2014 $91K Jan 1, 2014 Mar 31, 2014 10-K 2016-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.